DANA Inc
DANAbout the company
Dana Incorporated, together with its subsidiaries, provides power-conveyance and energy-management solutions for on-highway vehicles in North America, Europe, South America, and the Asia Pacific. The Light Vehicle segment provides axles, driveshafts, internal combustion engine (ICE), hybrid and electric transmissions, e-axle and e-transmission systems, inverters, electric motors, controllers, sealing and thermal products, e-sealing, e-thermal cooling systems, battery and electronics cooling, hydrogen fuel cell cooling, and new power industrial cooling.
Investment snapshot
Positive
3
BUY / PASS
Neutral / negative
3 / 10
NEUTRAL / FAIL
Median fair value
$14.25
-40.4% vs price
Models with upside
2 / 17
Positive margin of safety
Strongest signal
6 of 10 pass — Buffett, Lynch, Ackman +1 more object
Key risk
All 8 investors flag DAN's efficiency
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | FAIL · Rank #1635 (Top 52.8%) | NEUTRAL | FAIL | FAIL | FAIL | FAIL | FAIL | NEUTRAL | PASS | PASS | BUY | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||
| Margin of Safety | -130.3% | N/A | N/A | N/A | N/A | -837.3% | +29.7% | N/A | -57.1% | -67.7% | +5.3% | -4586.3% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-27 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-27 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-27 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-27 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-05 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-11-05 Score computed: 2026-11-14 |
Where It Passes
- Cash Flow60% pass✓ 8✗ 4▾
6 of 10 pass — Buffett, Lynch, Ackman +1 more object
Free Cash Flow Proxy✗BuffettPositive and growingFCF Positive and Growing$87.0M✗LynchPositive and growingOperating Cash Flow$512.0M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=6.56%, ROA=1.09%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)5.2x✓Dreman< 8xP/E or FCF YieldP/E=37.3x, FCF Yield=12.5%✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive16/17 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap3.2%✗Ackman>= 4%Price / FCF per Share9.0x✓Ackman<= 25Positive Operating Cash Flow frequency23/23 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$87.0M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+3.65%; #1892/4519 (top 41.9%)✗OshaughnessyTop 10% of eligible cross-section
Where It Falls Short
- Efficiency0% pass✗ 11▾
All 8 investors flag DAN's efficiency
Current Ratio1.13✗Graham>= 2.0ROIC (3-5 yr avg)1.4%✗Buffett> 10%ROIC - WACC-8.6%✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)7.1%✗Greenblatt> 25%Current Ratio Change YoY1.45 -> 1.17✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.03x -> 0.96x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities1.13✗Dreman> 1.5Return on Invested Capital7.6%✗Munger> 15%ROIC (high and growing)FY2023: ROIC=-2.0%; FY2024: ROIC=-3.5%; FY2025: ROIC=3.2%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC7.3% (RR=95% x ROIC=7.6%)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)0/5 years above 12% (latest 3.2%)✗SleepROIC > 12% in a majority of years - Growth13% pass✓ 3✗ 10▾
7 of 8 flag DAN's growth — Graham, Lynch, Dreman +4 more
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 37.3x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-17.0%✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -11.2% vs Rev: -8.9%✓LynchInventory growth < Revenue growthEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR-3.3% CAGR over 14 years✗Dreman> 5% annualizedPositive Net Income Frequency24/28 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-3.0%✗Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR-17.0% CAGR over 4 years✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 5.0% -> 8.0%, operating margin -1.4% -> 1.9%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR1.1%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR-17.0% over 4 years✗Neff7%-20% annualized - Valuation15% pass✓ 5✗ 23▾
11 of 13 flag DAN's valuation — Graham, Lynch, Greenblatt +8 more
Price / 3-yr avg EPS140.6x✗Graham<= 15xPrice-to-Book Ratio3.2x✗Graham<= 1.5xP/E x P/B449.10✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 37.3x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value3.1%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=3.1%, ROC=7.1%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS37.3x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)5.2x✓Dreman< 8xPrice / Book Value per Share3.2x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=37.3x✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=37.3x, FCF Yield=12.5%✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=37.3x, P/B=3.2x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-837.3% (IV=$2.55 vs Price=$23.90)✗Marks>= 20% below intrinsic valuePrice / FCF per Share9.0x✓Ackman<= 25Price vs. Trailing Low179% of trailing low ($13.33)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization+43.88%; #153/6340 (top 2.4%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.7192; #2138/6449 (top 33.2%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS37.3x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E-0.40✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share3.49x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change-38.5%✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+3.2618; #759/5247 (top 14.5%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+3.65%; #1892/4519 (top 41.9%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-34.45%; #4597/6202 (top 74.1%)✗OshaughnessyTop 10% of eligible cross-section - Profitability19% pass✓ 14✗ 21▾
13 of 16 flag DAN's profitability — Graham, Buffett, Lynch +10 more
Positive EPS (10 years)11/29 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)24/29 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)0.6%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)1.9% (latest)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy✗BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 37.3x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-17.0%✗Lynch15-30% (Fast Grower); > 0% to passROE61.0%✓Lynch> 15%EBIT / Enterprise Value3.1%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=3.1%, ROC=7.1%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets1.09%✓PiotroskiROA > 0ROA Change YoY-0.76% -> 1.09% (delta: +1.85%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=6.56%, ROA=1.09%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY4.9% -> 8.0%✓PiotroskiImproved YoYPre-Tax Income / Revenue1.5%✗Dreman>= 8%Net Income / Shareholders' Equity61.0%✓Dreman> 12%Margin of SafetyP/E=37.3x, P/B=3.2x✗PabraiP/B < 1.5 or P/E < 15Return on Equity2.8% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic Value-837.3% (IV=$2.55 vs Price=$23.90)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency24/28 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue3.2%✗Ackman>= 15%Net Income / Shareholders Equity61.0%✓Ackman>= 15%5-Year EPS CAGR-17.0% CAGR over 4 years✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend-1.4% (2023) -> 1.9% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 5.0% -> 8.0%, operating margin -1.4% -> 1.9%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization+43.88%; #153/6340 (top 2.4%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+7.71%; #2949/3702 (top 79.7%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+61.01%; #173/5226 (top 3.3%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0196; #1413/5884 (top 24.0%)✓AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR-17.0% over 4 years✗Neff7%-20% annualizedPositive Diluted-EPS Years7/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Verdicts21% pass✓ 3✗ 11▾
Split decision: 10 FAIL · 3 NEUTRAL · 2 PASS · 1 BUY
Overall verdict✗GrahamFAIL (1/9)✗BuffettFAIL (0/9)✗LynchFAIL (2/7)✗GreenblattRank #1635•PiotroskiNEUTRAL (F-Score 7)✗DremanFAIL (4/11)✗MungerFAIL (1/4)✗PabraiFAIL (1/3)✗AkreFAIL (1/6)✗MarksFAIL (2/5)•AckmanNEUTRAL (6/9)✓TempletonPASS (4/8)✓SleepPASS (3/6)✓AsnessBUY (Rank #350/2370 (Top 14.8%))✗NeffFAIL (3/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked) - Debt & Leverage25% pass✓ 5✗ 10▾
9 of 12 flag DAN's debt & leverage — Graham, Buffett, Lynch +6 more
LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.50, IC: 2.2x✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.50✗Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities1.13✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.50✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.50✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=0.8x, D/EBITDA=N/A (D&A unavailable)✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.50✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.5041; #2470/4210 (top 58.7%)✗AsnessTop 30% of eligible cross-section - Valuation models29% pass✓ 2✗ 5▾
Models split on DAN at $23.90 — fair values range $0.51–$33.98
Graham fair value$10.38✗Graham-130.3% margin vs $23.90Dreman fair value$2.55✗Dreman-837.3% margin vs $23.90Munger fair value$33.98✓Munger+29.7% margin vs $23.90Akre fair value$15.21✗Akre-57.1% margin vs $23.90Marks fair value$14.25✗Marks-67.7% margin vs $23.90Ackman fair value$25.23✓Ackman+5.3% margin vs $23.90Templeton fair value$0.51✗Templeton-4586.3% margin vs $23.90
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 22.3% of shares last year, 22.1% over two.
- Buybacks
- $650.0M
- Dividends
- $54.0M
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-09-30 2025-10-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: operating income, ebit, pre tax income, interest expense, operating cash flow, capex, dividends paid, buybacks. | Q3 FY 2026 2026-07-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex, dividends paid, buybacks. | Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex, dividends paid, buybacks. | Q1 FY 2026 2026-01-01 – 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.4Bcurrent | -- | -- | -- | $3.2Best. | $2.2Best. | $1.8Best. | $2.4Best. | $2.8Best. |
| Revenue | $7.8B↓9% | $2.0B↑6% | $2.0B↑4% | $1.9B↓21% | $7.5B↓3% | $7.7B↑2% | $7.6B↓25% | $10.2B↑14% | $8.9B |
| Operating Income | $249.0M↑137% | $92.0M↑74% | $76.0M↑375% | $19.0M↓74% | $139.0M↑179% | -$176.0M↓63% | -$108.0M↓226% | $86.0M↓78% | $395.0M |
| Net Income | $1.0B↑1804% | $15.0M↓82% | -$5.0M↓119% | $1.1B↑4248% | $85.0M↑249% | -$57.0M↓250% | $38.0M↑116% | -$242.0M↓223% | $197.0M |
| EPS (Diluted) | -- | $0.14↓78% | $-0.05↓126% | $9.89↑5718% | $0.64↑264% | $-0.39↓250% | $0.26↑115% | $-1.69↓225% | $1.35 |
| Gross Margin | — | — | — | — | 8.0%↑64% | 4.9%↓1% | 5.0%↓34% | 7.5%↓20% | 9.4% |
| Operating Margin | 3.2%↑160% | 4.5%↑63% | 3.8%↑357% | 1.0%↓67% | 1.9%↑181% | -2.3%↓60% | -1.4%↓268% | 0.8%↓81% | 4.4% |
| ROE | 61.0%↑1113% | — | — | — | 10.1%↑337% | -4.3%↓277% | 2.4%↑115% | -15.6%↓252% | 10.2% |
| Total Debt | $865.0M↓67% | $865.0M↓67% | $1.3B↓48% | $1.3B↓52% | $2.6B | $2.6B↓1% | $2.6B↑12% | $2.4B↓2% | $2.4B |
| Shareholders' Equity | $1.7B↑57% | $1.7B↑57% | $1.9B↑59% | $2.0B↑42% | $840.0M↓37% | $1.3B↓15% | $1.6B↑2% | $1.6B↓19% | $1.9B |
| Current Ratio | 1.13↓14% | 1.13↓14% | 1.49↑9% | 1.57↑10% | 1.17↓19% | 1.45↓8% | 1.58↑2% | 1.54↓6% | 1.65 |
| Debt / Equity | 0.50↓79% | 0.50↓79% | 0.70↓67% | 0.64↓66% | 3.09↑58% | 1.95↑17% | 1.67↑10% | 1.52↑22% | 1.25 |
| Operating Cash Flow | $422.0M↑3% | $102.0M↓8% | $109.0M↑241% | -$195.0M↓427% | $512.0M↑14% | $450.0M↓5% | $476.0M↓27% | $649.0M↑311% | $158.0M |
| Free Cash Flow | $87.0M↓15% | $32.0M↓48% | -$33.0M↓1200% | -$257.0M↓129% | $298.0M↑116% | $138.0M↑182% | $49.0M↓77% | $209.0M↑199% | -$211.0M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Automobiles and Trucks
DAN vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tesla, Inc.TSLA | $1.54T | $390.22 | $94.8B | $3.8B | 4.6% | 0.02 | 4.6% | 2.16 | 2/9 | 5/9 | 2/7 | 0/3 | F-Score 5 | 3/11 |
| General Motors CoGM | $72.5B | $86.00 | $185.0B | $2.7B | 4.4% | 2.15 | 1.6% | 1.17 | 3/9 | 1/9 | 0/7 | 0/3 | F-Score 6 | 2/11 |
| PACCAR INCPCAR | $56.2B | $106.66 | $28.4B | $2.4B | 12.3% | 0.00 | — | — | 3/9 | 3/9 | 2/7 | 0/3 | F-Score 4 | 4/11 |
| FORD MOTOR COF | $47.6B | $11.91 | $187.3B | $8.2B | -22.7% | — | -4.9% | 1.07 | 2/9 | 0/9 | 1/7 | 0/3 | F-Score 4 | 3/11 |
| HONDA MOTOR CO LTDHMC | $44.5B | $34.30 | $145.0B | $5.6B | 6.8% | 0.71 | 5.6% | 1.36 | 1/9 | 2/9 | 1/7 | 0/3 | F-Score 4 | 3/11 |
| MAGNA INTERNATIONAL INCMGA | $16.0B | $61.82 | $42.0B | $829.0M | 6.6% | 0.38 | — | 1.25 | 3/9 | 2/9 | 2/7 | 0/3 | F-Score 6 | 3/11 |
| BORGWARNER INCBWA | $10.2B | $50.89 | $14.3B | $277.0M | 5.1% | 0.72 | 3.7% | 2.07 | 1/9 | 2/9 | 0/7 | 0/3 | F-Score 6 | 3/11 |
| OSHKOSH CORPOSK | $8.6B | $141.78 | $10.4B | $647.0M | 14.3% | 0.24 | 9.0% | 1.94 | 2/9 | 5/9 | 4/7 | 0/3 | F-Score 5 | 3/11 |